secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001493152-26-017960
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric closes $5M private placement of shares and warrants with potential $8.9M additional proceeds
--------------------------------------------------------------------------------

- Gross proceeds of ~$5M from sale of 2.22M shares/pre-funded warrants; potential $8.9M more if warrants exercised.
- Warrants have exercise price of $2.00; Series I expire in 5 yrs, Series J in 18 months post-registration effective date.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee, 1% mgmt fee, and place agent warrants.
- Proceeds to be used for product development, working capital, and general corporate purposes.
- Offering closed on April 17, 2026 at $2.25 per share/warrant unit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315226017960/0001493152-26-017960-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315226017960/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-017960

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer